Primary Outcomes Logo

The Future of AI and Personalized Cancer Care:

How can patient empowerment accelerate improved cancer outcomes?

photo of panelists at Outcomes4Me's Pre-ASCO symposium

The Future of AI and Personalized Cancer Care:

How can patient empowerment accelerate improved cancer outcomes?

photo of panelists at Outcomes4Me's Pre-ASCO symposium

On June 2, 2023, we were honored to host a pre-ASCO Symposium where we brought together patients, practitioners, and experts in life sciences, digital health, policy, and advocacy to delve into the transformative power of generative AI in the delivery of cancer care.

See highlights from the Symposium below.

Discussion Highlights: Putting Patients First

Play Video

Discussion Highlights: Creating the Ecosystem for Equitable Patient Empowerment

Play Video

Partnering with Medicine & Industry

Play Video

The Patient Voice

Play Video

Want to see more? You can!

Three important discussions

Panel 1: AI in support of delivering patient-centric, guideline-concordant cancer care

In the age of AI, oncologists now have an opportunity to leverage patient-reported outcomes and real-world data to drive guideline-concordant care. Join us as we explore AI’s role in supporting physician decision-making and its ability to, in turn, better serve patients.

Panel 2: The role of AI in advancing equitable clinical trial recruitment and access

Join us as our panel of experts and patient advocates discusses the role of AI & digital health solutions in equitable clinical trial recruitment and examine how AI-driven patient empowerment and self-advocacy can contribute to clinical-trial matching.

Panel 3: The value of AI-powered, direct-to-patient activation in the consumer privacy era

Explore how opt-in AI can empower patients with personalized, relevant information, and how this approach coupled with true patient ownership of their medical records will both support the pharmaceutical industry’s commercial goals but also better serve patients.

Industry experts & patient advocate speakers

Maya R. Said, ScD

Founder & CEO, Outcomes4Me

Sunil Verma, MD

Senior VP, Global Head of Oncology, Medical, AstraZeneca

Aradhana Ghosh, MD

VP, Oncology Informatics,
Labcorp Oncology

Arun Krishna, PhD

VP, Head of US Lung Cancer Business, AstraZeneca

Crystal S. Denlinger, MD, FACP

Senior VP, Chief Scientific Officer, NCCN©

V.K. Gadi, MD, PhD

Deputy Director, University of Illinois Cancer Center

Kimberly Richardson

Founder, Black Cancer Collaborative, Breast & Ovarian Cancer Survivor

Prasanth Reddy, MD, MPH, FACP

Senior VP & Global Head of Enterprise Oncology, Labcorp

Debra Friedman, MD, MS

Director, Pediatric Hematology & Oncology, Vanderbilt-Ingram Cancer Center

Steven Isakoff, MD, PhD

Associate Director, Clinical Research, Mass General Cancer Center

Chadi Nabhan, MD, MBA, FACP

Senior VP & Chairman, Caris Precision Oncology Alliance

Susan Manber

Chief Patient Officer,
Publicis Health

Grace Cordovano, PhD, BCPA

Founder, Enlightening Results

Suzanne Garner

Director of Marketing & Community, Outcomes4Me, Breast Cancer Survivor

Kyle Holen, MD

SVP Head of Development, Therapeutics and Oncology, Moderna